The researcher is Steven Goodman, PhD, associate professor of pediatrics at the Ohio State College of Medicine, principal investigator at the Research Institute of Nationwide Children’s Hospital in Columbus and a member of the scientific board for Ohio-based biotechnology company ProclaRx.
According to Dr. Goodman, ProclaRx’s new technology can break down the physical barriers that protect bacteria and prevent antibiotics from attacking chronic infections.
ProclaRx CEO Joseph D. Kittle Jr., PhD, noted the technology is “unusual in that it can support both therapeutic as well as medical device products.”
More articles on bacterial infections:
Researchers reveal ‘tentacles’ UTI bacteria use to stay put during infection
Princeton researchers show how bacteria communicate, create infections
Deadly bacteria flew under many scientists’ radar, until now: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
